banner ad
banner ad

jeff

rss feed

Botox – the smooth way to get ahead in business

July 20, 2011 | 0

When solicitor Mark Roberts has an important court appearance looming, the preparation is often the same.  Arduous working days, sleepless nights and sometimes a week or so in advance: Botox. But this is not about eradicating wrinkles. For Roberts, who deals in commercial litigation, it is his edge in an ever competitive market.

Read More

Quick shot replacing nip, tuck

July 18, 2011 | 0

Demand for minimally invasive cosmetic procedures showed a three-digit increase over the last decade, with Botox leading the way for those seeking to look younger or better. As of last month, would-be patients can consider a new product that uses their own collagen cells, which are multiplied in a lab to create an injectable substance […]

Read More

Botox Training with the IAPAM Helps Physicians Boost Profits

July 8, 2011 | 0

As the demand for minimally-invasive treatments continues to rise, specifically the demand for Botox, dermal fillers and other cosmetic injectables, physicians who are expertly trained through multi-day botox training programs like the IAPAM’s Aesthetic Medicine Symposium, can capture this growing market and greatly benefit their practice’s bottom line.   As reported by the IAPAM and […]

Read More

Secrets to a Profitable Aesthetic Medicine Practice

July 7, 2011 | 0

As the Executive-Director of the IAPAM (International Association for Physicians in Aesthetic Medicine) I receive many calls and emails from physicians looking at entering the aesthetic medicine industry. The most common request is for Botox training, many believe by only offering Botox, they will be on their way to vast riches. The reality is that […]

Read More

Allergan Receives FDA Approval for First-of-Its-Kind, Fully in vitro, Cell-Based Assay for BOTOX® and BOTOX® Cosmetic (onabotulinumtoxinA)

June 30, 2011 | 0

–Represents R&D Breakthrough in Commitment to Animal-Free Stability and Potency Testing for BOTOX® and BOTOX® Cosmetic–   IRVINE, Calif.–(BUSINESS WIRE)– Allergan, Inc. (NYSE:AGN) today announced the United States Food and Drug Administration (FDA) has approved a fully in vitro, cell-based assay for use in the stability and potency testing of BOTOX® (onabotulinumtoxinA) and BOTOX® Cosmetic. […]

Read More

Xeomin expected to drive down botulinum toxin prices when it reaches market

June 29, 2011 | 0

When it enters the U.S. market, Xeomin is expected to have a unit-to-unit equivalence to Botox, the standard aesthetic toxin in dermatology practices for years. Current off-label use hasn’t shown any particular clinical advantage for Xeomin (incobotulinumtoxinA, Merz) over Botox (onabotulinumtoxinA, Allergan) or Dysport (abobotulinumtoxinA, Medicis), but the new toxin will broaden clinicians’ aesthetic options […]

Read More

New trial tests Botox as a treatment for asthma

June 29, 2011 | 0

A new medical trial in Australia is set to test whether Botox can be used to help people with asthma breathe more easily. Botox is a drug which is most frequently used in cosmetic surgery as it can be injected to paralyse wrinkles and facial lines. The researchers hope the injections, which will be given […]

Read More

IAPAM’s hCG Training is Consistent with Dr. Oz regarding hCG for Weight Loss

June 28, 2011 | 0

The IAPAM has trained over 350 physicians on how to safely offer hCG for weight loss, and well over 10,000 patients have successfully lost weight using the IAPAM’s Exclusive hCG Protocol. The core principles of the IAPAM’s hCG Training are consistent with those outlined by Dr. Oz in his recent interview for First for Women […]

Read More

IAPAM’s hCG Training Gives Physicians Best Practices

June 22, 2011 | 0

The IAPAM offers physicians the industry’s best practices and resources for adding hCG for weight loss to a practice. Attendees receive all the tools they need to help them launch their hCG program, and with their IAPAM Membership, they also receive a year of practice support including access to the IAPAM Members Portal, containing hCG resources […]

Read More

Battle for Beauty: Botox or Dysport

June 22, 2011 | 0

Botox’s stranglehold on the ‘de-wrinkling’ market may have found a match. A new randomized study published online in the Archives of Facial Plastic Surgery, has found that Botox’s competitor Dysport is better at treating crow’s feet. The study compared the effectiveness of both cosmetic drugs is smoothing wrinkles in 90 volunteers. The researchers from the […]

Read More

banner ad
banner ad